Reply to Letter: "Infusion of CD133+ Bone Marrow-Derived Stem Cell After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy".
作者信息
Schulte am Esch Jan, Schmelzle Moritz, Duhme Constanze, Fuerst Guenter, Robson Simon C, Bode Johannes G, Krieg Andreas, Topp Stefan A, Haeussinger Dieter, Knoefel Wolfram T
机构信息
Heinrich Heine University of Duesseldorf, Germany Departement of General, Visceral and Transplantation Surgey Charité University of Berlin Campus Mitte Heinrich Heine University of Duesseldorf, Germany Heinrich Heine University of Dueseldorf, Germany Harvard Medical School, Boston, MA Heinrich Heine University of Duesseldorf, Germany Heinrich Heine University of Hamburg, Germany.
出版信息
Ann Surg. 2016 Mar;263(3):e44-5. doi: 10.1097/SLA.0000000000000849.
Abstract
摘要
相似文献
1
Reply to Letter: "Infusion of CD133+ Bone Marrow-Derived Stem Cell After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy".对信件的回复：“选择性门静脉栓塞术后输注CD133+骨髓源性干细胞可增强扩大右肝切除术后的功能性肝储备”
Ann Surg. 2016 Mar;263(3):e44-5. doi: 10.1097/SLA.0000000000000849.
2
Infusion of CD133+ Bone Marrow-derived Stem Cell After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy.
Ann Surg. 2016 Mar;263(3):e44-5. doi: 10.1097/SLA.0000000000000404.
3
Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study.选择性门静脉栓塞后输注 CD133+骨髓源性干细胞可增强扩大右半肝切除术后的功能性肝储备：一项回顾性单中心研究。
Ann Surg. 2012 Jan;255(1):79-85. doi: 10.1097/SLA.0b013e31823d7d08.
4
What is the role of bone marrow-derived stem cells in hepatic hypertrophy after portal vein embolization?骨髓源性干细胞在门静脉栓塞术后肝肥大中的作用是什么？
Ann Surg. 2015 Jan;261(1):e25-6. doi: 10.1097/SLA.0000000000000423.
5
[Stem cell-induced liver regeneration].[干细胞诱导的肝脏再生]
Zentralbl Chir. 2013 Apr;138(2):166-72. doi: 10.1055/s-0031-1271587. Epub 2011 Nov 15.
6
Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.自体CD133+骨髓细胞经门静脉应用于肝脏：支持肝再生的新概念。
Stem Cells. 2005 Apr;23(4):463-70. doi: 10.1634/stemcells.2004-0283.
7
Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.门静脉栓塞术联合自体CD133+骨髓干细胞促进肝脏再生：初步经验
Radiology. 2007 Apr;243(1):171-9. doi: 10.1148/radiol.2431060625. Epub 2007 Feb 20.
8
Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome (Br J Surg 2007; 94: 1386-1394).肝大部切除术前门静脉栓塞及其对肝脏再生、可切除性和预后的影响（《英国外科杂志》2007年；94卷：1386 - 1394页）
Br J Surg. 2008 Mar;95(3):398; author reply 398-9. doi: 10.1002/bjs.6166.
9
Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy.门静脉栓塞后序贯性术前同侧肝静脉栓塞以诱导肝胆恶性肿瘤患者肝脏进一步再生
Ann Surg. 2009 Apr;249(4):608-16. doi: 10.1097/SLA.0b013e31819ecc5c.
10
Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different?肝切除术后和门静脉栓塞（结扎）后的肝再生机制不同吗？
J Hepatobiliary Pancreat Surg. 2009;16(3):292-9. doi: 10.1007/s00534-009-0058-x. Epub 2009 Mar 31.
本文引用的文献
1
CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.CD39 调节造血干细胞募集并促进小鼠和人类肝部分切除术后的肝脏再生。
Ann Surg. 2013 Apr;257(4):693-701. doi: 10.1097/SLA.0b013e31826c3ec2.
2
In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection.分期肝切除中门静脉结扎的原位肝切除术促进剩余肝脏的快速再生。
Br J Surg. 2013 Feb;100(3):388-94. doi: 10.1002/bjs.8955. Epub 2012 Nov 2.
3
Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study.选择性门静脉栓塞后输注 CD133+骨髓源性干细胞可增强扩大右半肝切除术后的功能性肝储备：一项回顾性单中心研究。
Ann Surg. 2012 Jan;255(1):79-85. doi: 10.1097/SLA.0b013e31823d7d08.
4
Stem cell therapy for chronic liver disease--choosing the right tools for the job.慢性肝病的干细胞治疗——为这项工作选择合适的工具。
Gut. 2008 Feb;57(2):153-5. doi: 10.1136/gut.2007.134247.
5
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential.人间充质干细胞在肝脏再生医学中是一把双刃剑：植入与肝细胞分化对抗促纤维化潜能。
Gut. 2008 Feb;57(2):223-31. doi: 10.1136/gut.2006.111617. Epub 2007 Jul 16.
6
Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.自体CD133+骨髓细胞经门静脉应用于肝脏：支持肝再生的新概念。
Stem Cells. 2005 Apr;23(4):463-70. doi: 10.1634/stemcells.2004-0283.
7
Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.门静脉栓塞与门静脉结扎用于诱导未来肝剩余体积增大的比较
J Gastrointest Surg. 2002 Nov-Dec;6(6):905-13; discussion 913. doi: 10.1016/s1091-255x(02)00122-1.
Zotero 插件